Adaptive Biotechnologies Corp·4

Mar 9, 8:29 PM ET

LO FRANCIS 4

Research Summary

AI-generated summary

Updated

Adaptive Biotechnologies (ADPT) CPO Lo Francis Sells Shares

What Happened

Lo Francis, Chief People Officer of Adaptive Biotechnologies (ADPT), disposed of 38,074 shares on 2026-03-05 at $15.09 per share, for a total of $574,537. The sale was a "sell-to-cover" tied to RSU vesting and was used to satisfy tax withholding obligations, not a discretionary market trade.

Key Details

  • Transaction date and price: 2026-03-05 — 38,074 shares sold at $15.09 each. Total proceeds reported: $574,537.
  • Transaction code: S (sale); described as "open market or private sale" in the filing.
  • Footnote (F1): The sale was mandated to cover tax withholding for vested RSUs under the issuer's equity plan and "does not represent a discretionary trade by the Reporting Person."
  • Filing/timeliness: Form 4 filed 2026-03-09 (within the standard 2-business-day reporting window).
  • Shares owned after transaction: Not specified in the provided filing excerpt.

Context

Sell-to-cover transactions are routine administrative actions that occur when restricted stock units (RSUs) vest and the issuer or broker sells a portion of shares to cover required tax withholding. Such mandated sales generally do not indicate the insider's view on the company's near-term prospects. Purchases by insiders tend to be more informative than routine withholding sales.